294 related articles for article (PubMed ID: 29167573)
1. Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production.
Mogavero A; Maiorana MV; Zanutto S; Varinelli L; Bozzi F; Belfiore A; Volpi CC; Gloghini A; Pierotti MA; Gariboldi M
Sci Rep; 2017 Nov; 7(1):15992. PubMed ID: 29167573
[TBL] [Abstract][Full Text] [Related]
2. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
3. Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.
Abu El Maaty MA; Strassburger W; Qaiser T; Dabiri Y; Wölfl S
Mol Carcinog; 2017 Nov; 56(11):2486-2498. PubMed ID: 28618116
[TBL] [Abstract][Full Text] [Related]
4. Metformin induces G1 cell cycle arrest and inhibits cell proliferation in nasopharyngeal carcinoma cells.
Zhao L; Wen ZH; Jia CH; Li M; Luo SQ; Bai XC
Anat Rec (Hoboken); 2011 Aug; 294(8):1337-43. PubMed ID: 21717584
[TBL] [Abstract][Full Text] [Related]
5. Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy.
Zhao B; Luo J; Wang Y; Zhou L; Che J; Wang F; Peng S; Zhang G; Shang P
Oxid Med Cell Longev; 2019; 2019():9290728. PubMed ID: 31827709
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo anti-melanoma action of metformin.
Janjetovic K; Harhaji-Trajkovic L; Misirkic-Marjanovic M; Vucicevic L; Stevanovic D; Zogovic N; Sumarac-Dumanovic M; Micic D; Trajkovic V
Eur J Pharmacol; 2011 Oct; 668(3):373-82. PubMed ID: 21806981
[TBL] [Abstract][Full Text] [Related]
7. Metformin Inhibits the Urea Cycle and Reduces Putrescine Generation in Colorectal Cancer Cell Lines.
Zhang T; Hu L; Tang JF; Xu H; Tian K; Wu MN; Huang SY; Du YM; Zhou P; Lu RJ; He S; Xu JM; Si JJ; Li J; Chen DL; Ran JH
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915902
[TBL] [Abstract][Full Text] [Related]
8. Alkaloid-rich fraction of Ervatamia coronaria sensitizes colorectal cancer through modulating AMPK and mTOR signalling pathways.
Dutta N; Pemmaraju DB; Ghosh S; Ali A; Mondal A; Majumder C; Nelson VK; Mandal SC; Misra AK; Rengan AK; Ravichandiran V; Che CT; Gurova KV; Gudkov AV; Pal M
J Ethnopharmacol; 2022 Jan; 283():114666. PubMed ID: 34592338
[TBL] [Abstract][Full Text] [Related]
9. Metformin inhibits cell proliferation in SKM-1 cells via AMPK-mediated cell cycle arrest.
Zhou X; Kuang Y; Liang S; Wang L
J Pharmacol Sci; 2019 Dec; 141(4):146-152. PubMed ID: 31744691
[TBL] [Abstract][Full Text] [Related]
10. Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer.
Gwak H; Kim Y; An H; Dhanasekaran DN; Song YS
Mol Carcinog; 2017 Feb; 56(2):349-358. PubMed ID: 27128966
[TBL] [Abstract][Full Text] [Related]
11. Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Thent ZC; Zaidun NH; Azmi MF; Senin MI; Haslan H; Salehuddin R
Curr Drug Targets; 2017; 18(6):734-750. PubMed ID: 27919208
[TBL] [Abstract][Full Text] [Related]
12. Sulfonamide metformin derivatives induce mitochondrial-associated apoptosis and cell cycle arrest in breast cancer cells.
Markowicz-Piasecka M; Huttunen J; Zajda A; Sikora J; Huttunen KM
Chem Biol Interact; 2022 Jan; 352():109795. PubMed ID: 34953865
[TBL] [Abstract][Full Text] [Related]
13. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.
Cai X; Hu X; Tan X; Cheng W; Wang Q; Chen X; Guan Y; Chen C; Jing X
PLoS One; 2015; 10(7):e0133349. PubMed ID: 26196392
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and apoptosis inducing effects of citral via p53 and ROS-induced mitochondrial-mediated apoptosis in human colorectal HCT116 and HT29 cell lines.
Sheikh BY; Sarker MMR; Kamarudin MNA; Mohan G
Biomed Pharmacother; 2017 Dec; 96():834-846. PubMed ID: 29078261
[TBL] [Abstract][Full Text] [Related]
15. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumour effect of metformin in canine mammary gland tumour cells.
Saeki K; Watanabe M; Tsuboi M; Sugano S; Yoshitake R; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T
Vet J; 2015 Aug; 205(2):297-304. PubMed ID: 25981932
[TBL] [Abstract][Full Text] [Related]
17. Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling.
Shen P; Reineke LC; Knutsen E; Chen M; Pichler M; Ling H; Calin GA
Mol Oncol; 2018 Nov; 12(11):1856-1870. PubMed ID: 30221473
[TBL] [Abstract][Full Text] [Related]
18. Metformin suppresses CRC growth by inducing apoptosis via ADORA1.
Lan B; Zhang J; Zhang P; Zhang W; Yang S; Lu D; Li W; Dai Q
Front Biosci (Landmark Ed); 2017 Jan; 22(2):248-257. PubMed ID: 27814614
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
[TBL] [Abstract][Full Text] [Related]
20. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
